EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,439,000 | -20.1% | 28,735 | +0.4% | 0.03% | -22.2% |
Q2 2021 | $1,802,000 | -31.2% | 28,613 | +1.5% | 0.04% | -34.5% |
Q1 2021 | $2,620,000 | +11.4% | 28,200 | +7.4% | 0.06% | +1.9% |
Q4 2020 | $2,352,000 | +5.7% | 26,250 | +21.9% | 0.05% | -6.9% |
Q3 2020 | $2,225,000 | +3.0% | 21,536 | -21.1% | 0.06% | -7.9% |
Q2 2020 | $2,160,000 | +34.2% | 27,309 | -1.8% | 0.06% | +21.2% |
Q1 2020 | $1,609,000 | +1.6% | 27,808 | -5.3% | 0.05% | +30.0% |
Q4 2019 | $1,584,000 | +1.7% | 29,368 | -1.4% | 0.04% | -20.0% |
Q3 2019 | $1,558,000 | +7.9% | 29,793 | -0.3% | 0.05% | +8.7% |
Q2 2019 | $1,444,000 | -4.2% | 29,890 | +0.2% | 0.05% | -27.0% |
Q1 2019 | $1,507,000 | -19.6% | 29,825 | -5.6% | 0.06% | -30.8% |
Q4 2018 | $1,874,000 | -12.4% | 31,610 | -2.8% | 0.09% | -15.0% |
Q3 2018 | $2,140,000 | +29.4% | 32,505 | -0.8% | 0.11% | +24.4% |
Q2 2018 | $1,654,000 | -4.3% | 32,768 | -0.2% | 0.09% | -8.5% |
Q1 2018 | $1,729,000 | +16.7% | 32,833 | +3.0% | 0.09% | +1.1% |
Q4 2017 | $1,482,000 | – | 31,883 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |